Edward Cha

Edward Cha

Company: Genentech

Job title: Global Development Lead, GI CANCERS & COMBINATIONS

Seminars:

Panel Discussion – Clinical Program Development Takeaways: How Can Researchers & Drug Developers in Any Targeted, Immune, Chemo, ADC Therapies Unite & Collaborate Future Directions to Optimize Our Own Drugs & Overall Patient Outlook? 11:30 am

Learnings from the past, how have we each developed our drugs considering previous work published? How can we optimize our program for any of the GI Cancer Indications? Thoughts on translating an established candidate from another solid tumor into GI cancer Utilizing patient groups, precision oncology & early detection in our clinical programsRead more

day: Day Two

Speaker Q&A 9:50 am

Read more

day: Day One

Considerations for Pursuing GI Cancer Indications: Concept, Implementation & Clinical Results 9:00 am

Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.